Pressmeddelanden
REG
Coegin Pharma AB publishes Annual Report for 2025
Coegin Pharma AB ("Coegin" or the "Company") today announces that the Annual Report for 2025 is available on the Company's website, www.coeginpharma.com, and is also attached to...
REG
Kallelse till årsstämma i Coegin Pharma AB (publ)
Aktieägarna i Coegin Pharma AB kallas härmed till årsstämma torsdagen den 21 maj 2026 kl. 10.00 på Medicon Village, Scheeletorget 1, i Lund.
Rätt att delta och anmälan Aktieägare...
REG
Notice of annual general meeting in Coegin Pharma AB (publ)
The shareholders of Coegin Pharma AB are hereby invited to attend the Annual General Meeting on Thursday, 21 May 2026 at 10:00 a.m. at Medicon Village, Scheeletorget 1, Lund.
Rig...
Coegin Pharma expands commercial strategy with own-brand distribution model - launches VEXIENNE®
Coegin Pharma AB ("Coegin" or the "Company") today announces the expansion of its commercial strategy through the introduction of an own-brand distribution model for its Follicop...
Coegin Pharma's management acquires shares in the company
Coegin Pharma AB today announces that the company's CEO, CFO and CMO have acquired additional shares in the company.
CEO Jens Eriksson has acquired 24,293 shares, CFO Lars Bukhav...
Coegin Pharma receives first purchase order for new scalp serum
Coegin Pharma AB ("Coegin" or the "Company") today announces that it has received its first limited purchase order for the Company's newly introduced high-performance cosmetic sc...
Rapporter
Video
Finansiell kalender
Om Coegin Pharma
Coegin Pharma är ett svenskt innovationsbolag som utvecklar och kommersialiserar avancerade kosmetiska teknologier för hår och hud.
Webbplats
www.coeginpharma.com
Bransch
Bioteknik
Prenumerera
Få löpande information från Coegin Pharma via e-post.
Handelsinformation
Kurs 3,3 SEK (2026-05-15)
Förändring −12,93% (2025-05-15)